Multi-Agent Automation of Transforming Real Data into Privacy-Safe Synthetic Schemas

Manual processes for data de-identification, legal review, and IRB approval create massive bottlenecks. This workflow automates schema analysis, privacy-preserving transformation, and governance logging, enabling on-demand generation of compliant synthetic cohorts. Teams can spin up tailored datasets in days, not quarters, accelerating hypothesis testing and model iteration cycles by 80%.

Converting real EHR, claims, or imaging data into a usable synthetic schema requires extensive manual mapping, type conversion, and relationship preservation. Specialized agents handle schema inference, clinical coding system alignment (like ICD-10, LOINC), and generative model training orchestration. This removes weeks of repetitive data wrangling per project, freeing senior data engineers for higher-value architecture work.

Sharing real data requires complex legal agreements and carries re-identification risk. Automated privacy risk testing (k-anonymity, l-diversity) and audit trail generation provide defensible evidence for IRB and data use agreements. Synthetic proxies can be used to negotiate data partnerships in weeks, not months, by demonstrating utility without exposing protected health information (PHI).

Research on rare conditions or specific biomarker-positive groups is crippled by insufficient sample sizes. This workflow uses conditional generative models to create statistically realistic cohorts of any size or specification. This allows for robust model training, clinical trial simulation, and counterfactual analysis where real data is impossible or unethical to acquire, turning data scarcity into a solvable engineering problem.

Beyond a one-off project, this workflow establishes a production-grade pipeline for continuous synthetic data generation. With automated monitoring for fidelity drift, cost optimization, and performance, it becomes a centralized, compliant data utility. This operational leverage allows entire organizations—from R&D to commercial teams—to iterate faster with a shared, privacy-safe source of truth.

The chronic shortage of diverse, high-quality training and validation data is the primary cause of AI project failure in healthcare. An on-demand synthetic data pipeline integrated with MLops platforms (like MLflow, Weights & Biases) ensures data scientists always have tailored datasets for each development stage. This reduces model failure rates, improves generalizability, and creates a predictable, data-abundant development environment.

The first agent in the orchestration ingests source data (e.g., from an EHR like Epic or a research OMOP database) to perform automated schema discovery. It maps primary/foreign keys, infers statistical distributions for each field, and identifies clinical coding systems (ICD-10, LOINC, CPT). This creates a prescriptive data model that defines what must be preserved in the synthetic output, ensuring downstream agents generate structurally valid records that plug directly into existing analytical pipelines.

This agent selects and trains the appropriate generative model (GAN, tabular diffusion, CTGAN) based on the analyzed schema. It handles the privacy-utility trade-off by applying differential privacy budgets or k-anonymity constraints during training. The agent orchestrates distributed training jobs on GPU clusters, monitors for mode collapse or fidelity drift, and triggers retraining if validation metrics degrade. Output is a production-ready model capable of generating an unlimited volume of synthetic records.

Acting on demand or a schedule, this agent executes the trained model to produce synthetic datasets. It performs critical post-processing: enforcing referential integrity across generated tables, validating that synthetic values fall within clinically plausible ranges (e.g., a creatinine level of 1000 mg/dL would be flagged), and formatting outputs to match the target system's requirements (CSV for analytics, FHIR bundles for sandboxes, or direct inserts into a test EDC like Medidata Rave).

This autonomous quality gate runs a battery of tests on each generated cohort. It compares distributions (using KS tests, propensity score metrics), pairwise correlations, and temporal logic against the real source data. It scores the synthetic dataset on a 0-100 scale for utility and flags any anomalies (e.g., a vanished rare disease subgroup) for human review. Failed batches are automatically routed back to the training agent for correction, creating a closed-loop improvement system.

The final agent handles compliance and operations. It attaches immutable metadata (lineage, privacy parameters) to each dataset, logs all access events, and enforces data use agreements. For self-service requests from researchers, it validates credentials against IAM systems, applies any required additional masking, and provisions the data to secure sandboxes or cloud storage. It generates audit-ready reports for IRB or privacy office review, documenting the entire synthetic generation lifecycle.

Build this using an orchestration framework like LangGraph or Prefect to manage the agent handoffs and state. Agents are deployed as containerized services, communicating via a message queue (e.g., RabbitMQ) for scalability. The system integrates at three key points: 1. Source Connectors (to EHRs, data lakes), 2. Validation Suites (statistical libraries, custom clinical logic), and 3. Sink Connectors (to research platforms, simulation environments). Rollout starts with a pilot on a single, well-understood data domain (e.g., cardiology lab values) before expanding to full patient journeys.

Business Impact Owner. Defines the target ROI: reduced data procurement timelines (from months to days), elimination of legal review bottlenecks for data sharing, and accelerated model development cycles. Approves the fidelity thresholds and risk tolerance for synthetic data utility versus privacy. Holds the budget and mandates integration with the enterprise data catalog and governance framework.

Solution Architect. Designs the multi-agent orchestration using LangGraph or CrewAI. Specifies the agents: a Schema Analysis Agent to profile source data distributions, a Relationship Mapping Agent to preserve clinical and temporal links, and a Generative Training Agent to condition models (e.g., GANs, diffusion) on sanitized statistics. Defines the API contracts between agents and the integration points with source systems (Epic, Cerner) and downstream sinks (Snowflake, S3).

Governance Gatekeeper. Mandates the implementation of differential privacy budgets, k-anonymity checks, and automated re-identification risk testing. Defines the audit trail requirements for the Synthetic Data Governance Agent, ensuring all generated cohorts are logged with lineage, parameters, and access events. Works with the architect to embed privacy metrics (e.g., ε-differential privacy) as a quality gate before data release.

Primary Consumer & Validator. Provides the clinical knowledge to ground the synthetic data. Defines the key statistical properties (distributions of lab values, co-morbidity relationships, treatment pathways) that must be preserved. Works with engineers to design the Fidelity Validation Agent, which runs automated checks (KS tests, propensity score metrics) and flags cohorts that fail. Uses the synthetic output for trial simulation or model training, providing feedback on utility.

Pipeline Operationalizer. Containerizes agent workloads, manages the CI/CD pipeline for model retraining, and implements monitoring for the production workflow. Uses tools like Datadog to track pipeline health, generation latency, and cloud costs. Builds the Pipeline Monitoring Agent to auto-scale resources and alert on fidelity drift. Ensures the synthetic data API is reliable and meets SLAs for internal research teams.

Alignment & Sequencing Lead. Manages the phased rollout: starting with a pilot on a single, well-understood data domain (e.g., synthetic lab results) before scaling to full EHR narratives and imaging. Facilitates sprint planning between the architect, data scientists, and compliance to balance feature development against governance requirements. Tracks velocity against the core business outcome: reducing the data bottleneck in the R&D lifecycle.